OTTO FERDINAND
Department of Neurology
Publications
21 Publications
2022
Journal Articles
The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation
Harrer, C; Otto, F; Radlberger, RF; Moser, T; Pilz, G; Wipfler, P; Harrer, A
CELLS-BASEL. 2022; 11(17): 2649
Reviews
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.
Moser, T; OSullivan, C; Otto, F; Hitzl, W; Pilz, G; Schwenker, K; Mrazek, C; Haschke-Becher, E; Trinka, E; Wipfler, P; Harrer, A;
Ther Adv Neurol Disord. 2022; 15: 17562864221092092
Full papers/articles (Journal)
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.
Moser, T; Otto, F; OSullivan, C; Hitzl, W; Pilz, G; Harrer, A; Trinka, E; Wipfler, P;
Mult Scler Relat Disord. 2022; 59: 103560
Full papers/articles (Journal)
Tick-Borne Encephalitis Virus RNA Found in Frozen Goatxxxs Milk in a Family Outbreak
Mylonaki, E; Seiberl, M; Jones, N; Bernhard, H; Otto, F; Pilz, G; Trinka, E; Wipfler, P
INT J MOL SCI. 2022; 23(19): 11632
Case Reports
Conference papers, proceedings, abstracts
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications
Moser, T; Otto, F; Pilz, G; Wipfler, P
EUR J NEUROL. 2022; 29: 395-395.
Abstracts (Journal)
2021
Journal Articles
The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
Harrer, C; Otto, F; Pilz, G; Haschke-Becher, E; Trinka, E; Hitzl, W; Wipfler, P; Harrer, A
FLUIDS BARRIERS CNS. 2021; 18(1): 40
Full papers/articles (Journal)
Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities.
Otto, F; Harrer, C; Pilz, G; Wipfler, P; Harrer, A;
Diagnostics (Basel). 2021; 12(1):
Reviews
2020
Journal Articles
Non-convulsive status epilepticus with right arm apraxia: A case report.
Ladisich, B; Otto, F; Machegger, L; Kleindienst, W; Trinka, E; Kuchukhidze, G;
Epilepsy Behav Rep. 2020; 14: 100371
Case Reports
Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study.
Mylonaki, E; Harrer, A; Pilz, G; Stalzer, P; Otto, F; Trinka, E; Wipfler, P;
J Clin Virol. 2020; 127: 104340
Full papers/articles (Journal)
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Otto, F; Moser, T; Feige, J; Seiberl, M; Bieler, L; Sellner, J;
Mult Scler Relat Disord. 2020; 42: 102108
Case Reports
Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.
Pilz, G; Steger, R; Wipfler, P; Otto, F; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroimmunol. 2020; 338:577087
Full papers/articles (Journal)
2019
Journal Articles
Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: a Comparative Study of Indication, Efficacy and Safety.
Moser, T; Harutyunyan, G; Karamyan, A; Otto, F; Bacher, C; Chroust, V; Leitinger, M; Novak, HF; Trinka, E; Sellner, J;
Brain Sci. 2019; 9(10):
Full papers/articles (Journal)
Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.
Pilz, G; Wipfler, P; Otto, F; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroinflammation. 2019; 16(1): 13
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria
Feige, J; Moser, T; Nagy, Z; Otto, F; Wipfler, P; Trinka, E; Sellner, J;
EUR J NEUROL. 2019; 26: 489-489.
Abstracts (Journal)
2018
Journal Articles
Acute treatment of stroke due to spontaneous calcified cerebral emboli causing large vessel occlusion.
Raghib, MF; Mutzenbach, JS; Rosler, C; Otto, F; Mc Coy, M; Muller-Thies-Broussalis, E; Pikija, S
J CLIN NEUROSCI. 2018; 47: 56-61.
Reviews
2017
Journal Articles
Causes of death in critically ill multiple sclerosis patients.
Karamyan, A; Brandtner, H; Grinzinger, S; Chroust, V; Bacher, C; Otto, F; Reisp, M; Hauer, L; Sellner, J;
Acta Neurol Scand. 2017; 136(4):305-309
Full papers/articles (Journal)
Susac"s syndrome: clinical course and epidemiology in a Central European population.
Seifert-Held, T; Langner-Wegscheider, BJ; Komposch, M; Simschitz, P; Franta, C; Teuchner, B; Offenbacher, H; Otto, F; Sellner, J; Rauschka, H; Fazekas, F;
Int J Neurosci. 2017; 127(9):776-780
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
First-line treatment with alemtuzumab for active multiple sclerosis: A nationwide post-marketing survey in Austria
Otto, F; Bajer-Kornek, B; Rommer, P; Leutmezer, F; Franta-Elmer, C; Oel, D; Latzko, C; Sellner, J
J NEUROL SCI. 2017; 381: 796-796.
Abstracts (Journal)
2016
Journal Articles
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report.
Mutzenbach, JS; Pikija, S; Otto, F; Halwachs, U; Weymayr, F; Sellner, J;
Ann Clin Transl Neurol. 2016; 3(11):-892.
Case Reports
Conference papers, proceedings, abstracts
Evidence of gender differences for initiation of therapy escalation in multiple sclerosis
Karamyan, A; Oppermann, K; Bacher, C; Otto, F; Pilz, G; Wipfler, P; Chroust, V; Sellner, J
MULT SCLER J. 2016; 22: 723-723.
Abstracts (Journal)
Prevalence and predictors of sexual dysfunction in multiple sclerosis: a cross-sectional study
Otto, F; Bacher, C; Chroust, V; Karamyan, A; Oppermann, K; Reisp, M; Pilz, G; Wipfler, P; Sellner, J
MULT SCLER J. 2016; 22: 727-727.
Abstracts (Journal)